Systematic proteome-wide Mendelian randomization to prioritize causal plasma proteins for skin cancers
Abstract Skin cancer is one of the most common cancers worldwide. Some risk factors including sun exposure and MC1R variants are recognized; however, the identification of additional genetic factors is essential for the development of novel therapeutic strategies. Here, we conducted a proteome-wide...
Saved in:
| Main Authors: | Masahiro Yoshikawa, Tomohiro Nakayama, Kensuke Asaba |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-12-01
|
| Series: | Communications Biology |
| Online Access: | https://doi.org/10.1038/s42003-024-07403-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proteome-wide mendelian randomization identifies causal plasma proteins in interstitial lung disease
by: Kunrong Yu, et al.
Published: (2025-01-01) -
Investigating causal relationships between plasma proteins and lung adenocarcinoma: result from proteomics and Mendelian randomization study
by: Ruoya Lv, et al.
Published: (2025-01-01) -
Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer
by: Meng-Hua Wu, et al.
Published: (2024-12-01) -
Mendelian randomization of plasma lipidome, inflammatory proteome and heart failure
by: Zequn Zheng, et al.
Published: (2024-12-01) -
Proteome-Wide Mendelian Randomization Analysis to Identify Potential Plasma Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer Subtypes
by: Lin Q, et al.
Published: (2024-12-01)